Ascendis Pharma A/S

Over the last 90 days, Ascendis Pharma (ASND) has recorded zero cyber incidents and zero red-flag 8-K filings—no bankruptcies, restatements, or officer departures detected in our ingestion pipeline. A clean recent window, however, does not eliminate structural risk; the absence of events in 90 days leaves material questions about dilution trajectory, financing runway, and longer-term capital structure exposure unanswered. The full $49 Report adds 12-month event history, dilution risk scoring, 8-K context analysis, and AI-flagged operational risk signals to round out the picture.